HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroyuki Inagawa Selected Research

TNF-SAM2

11/2006A soluble 17 kDa tumour necrosis factor (TNF) mutein, TNF-SAM2, with membrane-bound TNF-like biological characteristics.
7/2002Antitumor effects of isolated hypoxic hepatic perfusion (IHHP) with high-dose TNF against colonic liver metastases in a rat model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroyuki Inagawa Research Topics

Disease

21Neoplasms (Cancer)
08/2021 - 07/2002
6Inflammation (Inflammations)
08/2021 - 07/2011
5Infections
07/2018 - 06/2008
5Colonic Neoplasms (Colon Cancer)
07/2016 - 07/2011
5Neoplasm Metastasis (Metastasis)
07/2013 - 07/2002
4Body Weight (Weight, Body)
07/2018 - 07/2011
3Seasonal Allergic Rhinitis (Hay Fever)
08/2019 - 08/2015
3Hyperlipidemias (Hyperlipidemia)
01/2018 - 10/2011
3Hypersensitivity (Allergy)
08/2015 - 11/2009
3Lung Neoplasms (Lung Cancer)
08/2010 - 11/2005
3Tuberculosis (Tuberculoses)
03/2010 - 11/2007
2Atopic Dermatitis (Atopic Eczema)
01/2022 - 08/2015
2Cognitive Dysfunction
08/2021 - 01/2021
2Obesity
08/2019 - 07/2018
2Foreign Bodies (Foreign Body)
07/2018 - 08/2014
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 07/2016
2Adenocarcinoma of Lung
08/2010 - 11/2005
2Carcinoma (Carcinomatosis)
08/2010 - 11/2005
2Endometrial Neoplasms (Endometrial Cancer)
11/2005 - 05/2005
1Contact Dermatitis (Eczema, Contact)
01/2022
1Dementia (Dementias)
08/2021
1Atrophy
01/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
08/2020
1Autism Spectrum Disorder
08/2020
1Hypertension (High Blood Pressure)
08/2019
1Fatty Liver
07/2018
1Wounds and Injuries (Trauma)
07/2018
1Wound Infection (Wound Infections)
07/2018
1Varicose Veins (Varicose Vein)
07/2018
1Ulcer
07/2018
1Atherosclerosis
01/2018
1Memory Disorders (Memory Loss)
01/2018
1Constipation
07/2017
1Liver Neoplasms (Liver Cancer)
07/2016
1Avian Reticuloendotheliosis
05/2016
1Colitis
08/2015
1Cross Infection (Nosocomial Infection)
08/2015
1Osteoporosis
11/2014
1Vibrio Infections
09/2011
1Communicable Diseases (Infectious Diseases)
07/2011
1Colorectal Neoplasms (Colorectal Cancer)
08/2010
1Lewis Lung Carcinoma
08/2010
1Dermatitis
11/2009

Drug/Important Bio-Agent (IBA)

27LipopolysaccharidesIBA
01/2022 - 09/2004
6CytokinesIBA
08/2021 - 05/2004
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2011 - 05/2004
4Messenger RNA (mRNA)IBA
07/2016 - 07/2011
3Anti-Allergic Agents (Antiallergic Agents)IBA
08/2019 - 08/2010
3oxidized low density lipoproteinIBA
01/2018 - 10/2011
3Biological ProductsIBA
11/2006 - 11/2003
2Blood Glucose (Blood Sugar)IBA
08/2021 - 07/2018
2Acetic Acid (Vinegar)FDA LinkGeneric
08/2019 - 08/2015
2Peptides (Polypeptides)IBA
01/2018 - 05/2016
2Amyloid (Amyloid Fibrils)IBA
01/2018 - 07/2016
2Anti-Bacterial Agents (Antibiotics)IBA
07/2017 - 08/2015
2Toll-Like Receptors (Toll-Like Receptor)IBA
07/2017 - 07/2016
2Pharmaceutical PreparationsIBA
08/2015 - 11/2007
2PicibanilIBA
07/2011 - 03/2007
2Interleukin-12 (IL 12)IBA
08/2010 - 05/2004
2Rifampin (Rifampicin)FDA LinkGeneric
03/2010 - 11/2007
2Polylactic Acid-Polyglycolic Acid CopolymerIBA
03/2010 - 11/2007
2Antitubercular AgentsIBA
03/2010 - 11/2007
2TNF-SAM2IBA
11/2006 - 07/2002
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
11/2005 - 05/2005
2AntigensIBA
11/2005 - 11/2002
1Conditioned Culture MediaIBA
08/2021
1Streptozocin (Streptozotocin)FDA Link
08/2021
1XenobioticsIBA
08/2020
1Neuroprotective AgentsIBA
01/2020
1SaltsIBA
08/2019
1Povidone-Iodine (Betadine)FDA LinkGeneric
07/2018
1SugarsIBA
07/2018
1Gentamicins (Gentamicin)FDA LinkGeneric
07/2018
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2018
1Apolipoproteins E (ApoE)IBA
01/2018
1Drinking WaterIBA
01/2018
1monophosphoryl lipid AIBA
07/2016
1Transcription Factors (Transcription Factor)IBA
08/2015
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
08/2015
1Waste Products (Waste Product)IBA
08/2014
1Matrix Metalloproteinases (MMPs)IBA
07/2013
1TeaIBA
10/2011
1Glucose (Dextrose)FDA LinkGeneric
10/2011
1Double-Stranded RNA (RNA, Double Stranded)IBA
09/2011
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2011
1Interleukin-8 (Interleukin 8)IBA
07/2011
1Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2010
1doxifluridineIBA
08/2010
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
08/2010
1Coloring Agents (Dyes)IBA
08/2010

Therapy/Procedure

18Oral Administration
01/2022 - 08/2010
13Therapeutics
08/2020 - 11/2002
5Microspheres (Microsphere)
03/2010 - 08/2006
4Immunotherapy
08/2015 - 11/2002
2Immunomodulation
01/2020 - 05/2005
1Lasers (Laser)
07/2018
1Punctures
07/2018
1Fecal Microbiota Transplantation
08/2015
1Intravenous Administration
07/2011
1Biological Therapy
08/2010